ID: ALA150484

Max Phase: Preclinical

Molecular Formula: C13H16N2O2

Molecular Weight: 232.28

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCC1(c2ccccc2)CCC(=O)N(N)C1=O

Standard InChI:  InChI=1S/C13H16N2O2/c1-2-13(10-6-4-3-5-7-10)9-8-11(16)15(14)12(13)17/h3-7H,2,8-9,14H2,1H3

Standard InChI Key:  JDQVSLGOXITLIC-UHFFFAOYSA-N

Associated Targets(non-human)

Cytochrome P450 11A1 161 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 232.28Molecular Weight (Monoisotopic): 232.1212AlogP: 1.36#Rotatable Bonds: 2
Polar Surface Area: 63.40Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 2.27CX LogP: 1.83CX LogD: 1.83
Aromatic Rings: 1Heavy Atoms: 17QED Weighted: 0.48Np Likeness Score: -0.12

References

1. Foster AB, Jarman M, Leung CS, Rowlands MG, Taylor GN..  (1983)  Analogues of aminoglutethimide: selective inhibition of cholesterol side-chain cleavage.,  26  (1): [PMID:6827528] [10.1021/jm00355a011]

Source